Sanofi reported $1.95B in Net Income for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 36M 2272M
Amgen AMGN:US $ 1615M 406M
Aphria Inc APH:CN C$ -120598000 115.5M
AstraZeneca AZN:LN 1012M 364M
Astrazeneca AZN:US $ 1012M 364M
Bristol Myers Squibb BMY:US $ -10027M 11899M
Catalent CTLT:US $ 88.4M 6M
Corcept Therapeutics CORT:US $ 25.99M 4.37M
Eli Lilly And LLY:US $ 2116.8M 908.4M
Genmab GEN:DC DK 581M 51M
GlaxoSmithKline GSK:LN 677M 567M
Glaxosmithkline GSK:US $ 677M 567M
Gw Pharmaceuticals GWPH:US $ -12.19M 3.36M
JAZZ PHA JAZZ:US $ 133.41M 14.82M
Johnson & Johnson JNJ:US $ 1738M 1816M
Lannett LCI:US $ -171.95M 165.45M
Merk MRK:US $ -2094M 5035M
Novartis NVS:US $ 2094M 159M
Pfizer PFE:US $ 594M 1600M
Phibro Animal Health PAHC:US $ 12.8M 0.5M
Prestige Brands PBH:US $ 40.87M 3.72M
Teva Pharmaceutical Industries TEVA:US $ 150M 4499M
Zoetis ZTS:US $ 359M 120M